GSA Capital Partners LLP Sells 52,930 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

GSA Capital Partners LLP cut its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 84.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,880 shares of the medical instruments supplier’s stock after selling 52,930 shares during the quarter. GSA Capital Partners LLP’s holdings in DENTSPLY SIRONA were worth $267,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Scientech Research LLC acquired a new stake in DENTSPLY SIRONA during the 2nd quarter worth approximately $846,000. VELA Investment Management LLC acquired a new stake in shares of DENTSPLY SIRONA during the third quarter worth $2,168,000. M&G Plc bought a new stake in shares of DENTSPLY SIRONA in the second quarter valued at about $8,817,000. Virtu Financial LLC acquired a new position in shares of DENTSPLY SIRONA in the first quarter valued at about $1,027,000. Finally, Country Club Bank acquired a new position in shares of DENTSPLY SIRONA in the third quarter valued at about $4,084,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on XRAY. StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Tuesday, November 19th. Leerink Partners downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Needham & Company LLC lowered their price objective on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. Evercore ISI cut their target price on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Finally, Leerink Partnrs lowered DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Seven investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Hold” and an average target price of $29.50.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY opened at $18.77 on Friday. The company has a fifty day moving average price of $23.25 and a 200-day moving average price of $25.09. The firm has a market cap of $3.73 billion, a price-to-earnings ratio of -9.07, a PEG ratio of 1.83 and a beta of 1.02. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA Inc. has a 1 year low of $17.21 and a 1 year high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. During the same period in the prior year, the company posted $0.49 earnings per share. DENTSPLY SIRONA’s quarterly revenue was up .4% on a year-over-year basis. As a group, equities research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.